Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib

Keyphrases

• Human Disease 100%
• Recent Advances 100%
• Human Biology 100%
• Spleen Tyrosine Kinase 100%
• Spleen Tyrosine Kinase Inhibitor 100%
• Fostamatinib 100%
• Immune Thrombocytopenia 80%
• Clinical Trials 20%
• COVID-19 20%
• Hematological Malignancies 20%
• Autoimmune Disease 20%
• Risk Reduction 20%
• Autoimmune 20%
• Thrombosis 20%
• Thrombotic Risk 20%
• Clinical Response 20%
• Signal Transduction Pathway 20%
• Biological Properties 20%
• Regulatory Molecules 20%
• Narrative Review 20%
• Ongoing Trials 20%
• Thrombotic Events 20%
• Multiple Signaling Pathways 20%
• Disease Pathways 20%
• Normal Haemostasis 20%
• Tyrosine Kinase Signaling Pathway 20%
• COVID-19 Pathogenesis 20%
• Warm Autoimmune Hemolytic Anemia 20%

Medicine and Dentistry

• Janus Kinase 1 100%
• Protein Kinase Syk 100%
• Fostamatinib 100%
• Protein Kinase Syk Inhibitor 100%
• Diseases 100%
• Idiopathic Thrombocytopenic Purpura 80%
• COVID-19 40%
• Cell Signaling Pathway 40%
• Clinical Trial 20%
• Hematologic Malignancy 20%
• Thrombosis 20%
• Blood Stasis 20%
• Disease 20%
• Signal Transduction Pathway 20%
• Kinase Signaling 20%
• Pathogenesis of Autoimmune Disease 20%
• Evans Syndrome 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Janus Kinase 1 100%
• Protein Kinase Syk 100%
• Fostamatinib 100%
• Protein Kinase Syk Inhibitor 100%
• Diseases 100%
• Idiopathic Thrombocytopenic Purpura 80%
• Clinical Trial 20%
• Autoimmune Disease 20%
• Thrombosis 20%
• Blood Stasis 20%
• Hematologic Malignancy 20%
• Autoimmune Hemolytic Anemia 20%